{"source": "The New York Times", "lead_paragraph": "A Bristol-Myers drug shows promise in treating a heart rhythm disorder, and others combat postsurgical clotting and deep vein thrombosis.", "keywords": [{"rank": "1", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Stroke", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Blood", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Blood Clots", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "Deep-Vein Thrombosis", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Bristol-Myers Squibb Co", "is_major": "N", "name": "organizations"}], "multimedia": [], "snippet": "A Bristol-Myers drug shows promise in treating a heart rhythm disorder, and others combat postsurgical clotting and deep vein thrombosis.", "print_page": "7", "blog": [], "headline": {"main": "New Rivals to Warfarin as Blood Clot Preventer", "seo": "New Drugs Rival Warfarin as Blood Clot Preventer", "print_headline": "New Rivals to Warfarin As Blood Clot Preventer"}, "_id": "541a208238f0d80959e6c2f4", "web_url": "http://www.nytimes.com/2010/09/01/business/01drug.html", "slideshow_credits": null, "byline": {"person": [{"organization": "", "rank": 1, "role": "reported", "lastname": "SINGER", "firstname": "Natasha"}], "original": "By NATASHA SINGER", "contributor": ""}, "news_desk": "Business", "word_count": "595", "document_type": "article", "type_of_material": "News", "abstract": null, "pub_date": "2010-09-01T00:00:00Z", "subsection_name": null, "section_name": "Business Day"}